Table 2.
Multivariate regression analyses for association between hyperuricemia and heart rate irregularity.
| Prevalence % (SE) |
OR (95% CI) | ||||
|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 4 | ||
| Uric acid, continuous (per mg/dL) | 1.28 (1.09–1.51) |
1.28 (1.07–1.53) |
1.30 (1.08–1.57) |
1.30 (1.08–1.57) |
|
| p | 0.0029 | 0.0071 | 0.0049 | 0.0051 | |
| Hyperuricemia | |||||
| No | 0.78 (0.09) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) |
| Yes | 2.13 (0.47) |
2.79 (1.70–4.57) |
2.79 (1.68–4.63) |
2.98 (1.71–5.18) |
3.00 (1.72–5.24) |
| p | <0.0001 | <0.0001 | <0.0001 | 0.0001 | 0.0001 |
Model 1 is a non-adjusted model. Model 2 is adjusted for age and sex. Model 3 is adjusted for model 2 + body mass index, smoking, drinking, hypertension, and diabetes mellitus. Model 4 is adjusted for model 3 + cardiovascular disease. Cardiovascular disease is defined as a diagnosis of stroke or myocardial infarction or angina by a physician.